Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Exelixis (EXEL)

Exelixis Q4 revenue rises to $598.7 million; 2026 financial guidance maintained

Positive Impact 3 of 5 earnings Written later

Exelixis reported fourth-quarter and full-year 2025 results on February 10, 2026. Total revenues rose to $598.7 million in the quarter from $566.8 million a year earlier, and GAAP diluted EPS was $0.88 versus $0.48, while the company maintained its previously provided 2026 financial guidance.

Key points

  • Q4 2025 total revenues were $598.7 million, up from $566.8 million in Q4 2024; FY 2025 total revenues were $2.320 billion, up from $2.169 billion.
  • Q4 2025 GAAP diluted EPS was $0.88 versus $0.48; FY 2025 GAAP diluted EPS was $2.78 versus $1.76.
  • Collaboration revenues for FY 2025 fell to $197.3 million from $359.3 million, mainly due to lower milestone-related revenue.
  • Exelixis maintained 2026 guidance, including total revenues of $2.525 billion to $2.625 billion, and authorized up to an additional $750 million in stock repurchases before December 31, 2026.

The filing

CompanyExelixis (EXEL)
Form8-K, current report
Filed with the SECFeb 10, 2026, 4:08 PM ET
Accession number0000939767-26-000019

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.